HOME >> MEDICINE >> NEWS
American Thoracic Society Journal news tips for December 2003 (second issue)

INHALED CORTICOSTEROID USE SHOWS NO SIGNIFICANT EFFECT ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE MORTALITY OR EXACERBATIONS

Describing results that contrast sharply with those from several prior observational studies by other biomedical scientists, investigators found that, in a large cohort of patients with chronic obstructive pulmonary disease (COPD), there was no significant effect from inhaled corticosteroid use on either patient mortality rate, the number of COPD exacerbations, or COPD-related hospital stays. Researchers presented data from 2,654 COPD patients who were prescribed inhaled corticosteroids for at least 80 percent of a 90-day period during the trial. There were 5,398 COPD patients who never had used inhaled corticosteroids also involved in the analysis. (COPD patients have a persistent obstruction of the airways associated with either severe emphysema or chronic bronchitis. The disease usually results from smoking.) The study authors said that they did not find a significant reduction in mortality for average inhaled steroid use at either a low, medium, or high dose. Nor did they see any association between inhaled corticosteroid use and reduced hospitalizations or exacerbations due to COPD. According to the authors, during a mean follow-up period of 544 days, 1,052 patients of the total included in the study died, 559 were hospitalized for COPD-associated symptoms, and 1,287 made an outpatient visit for a COPD exacerbation. The authors noted that several large prior observational studies had shown that inhaled corticosteorids, as used in clinical practice, were associated with a significant reduction in mortality or exacerbations. They attributed the difference in results to a statistical bias during the prior studies. The research is published in the second issue for December 2003 of the American Thoracic Society's peer-reviewed American Journal of Respiratory and Critical Care Medicine.

DEEP VEIN THROMBOSI
'"/>

Contact: Cathy Carlomagno
ccarlomagno@thoracic.org
212-315-6442
American Thoracic Society
16-Dec-2003


Page: 1 2 3

Related medicine news :

1. Consumers with disabilities empowered by American Disabilities Act
2. Definition of persistent vegetative state available from American Academy of Neurology
3. African-American women with endometrial cancer have more aggressive cancer than Caucasian women
4. New colorectal cancer screening recommendations for African Americans
5. American Thoracic Society Journal news tips for March 2005 (second issue)
6. Community care tops medical care at preventing heart disease in black Americans
7. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
8. Obesity among African-American stroke survivors increases risk factors for recurrent stroke
9. Awards & fellowships at the International & American Association for Dental Research General Session
10. American Academy of Neurology presents 57th Annual Meeting in Miami Beach
11. News tips from the 2005, 54th Annual Scientific Sessions of the American College of Cardiology

Post Your Comments:
(Date:8/22/2014)... 11 (BIM) deletion in advanced non-small cell lung ... survival (PFS) in epidermal growth factor receptor (EGFR) ... patients. Also, BIM deletion independently predicts overall survival ... protein can activate the programmed cell death also ... deletion has been detected in 12.8% of the ...
(Date:8/22/2014)... 2014 Paying tuition and other related ... coming year for four nurse educators pursuing advanced degrees, ... for Nursing Foundation for Nursing Education . This year’s ... $10,000 more than in 2013, thanks to these named ... Elizabeth Isaac Marcil Endowment Funds, both donated by Kathy ...
(Date:8/22/2014)... Eagerly embracing intended parents around the globe, ... offers the top male infertility programs — run by ... network of IVFinMexico.com continues to shape modern ... female and male infertility, advanced research and education. , ... eminently set by company CEO and Founder Tolga Umar ...
(Date:8/22/2014)... effort to sterilize feral cats reduced the number of felines ... new study reveals. "We investigated whether we ever could ... Dr. Julie Levy, a professor of shelter medicine at the ... university news release. "Neutering a few cats here ... we wanted to pick a focused area and throw all ...
(Date:8/22/2014)... Oklahoma (PRWEB) August 22, 2014 A national ... moving into new offices with room to grow. , Headquarters ... relocating to a 60,000-square-foot office building at 8516 N.W. Expressway ... – named one of the Oklahoma’s best places to work ... staff. The company has hired 120 in the past two ...
Breaking Medicine News(10 mins):Health News:Deletion predicts survival in advanced non-small cell lung cancer 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 4Health News:Neutering Project Curbed Feral Cat Population 2Health News:Fast-growing 180 Medical Moves Into New 60,000-square-foot Office in Oklahoma City 2
(Date:8/22/2014)... , Aug. 22, 2014 Today, the ... modify the religious "accommodation" but still require religious ... have an abortifacient effect, including Plan B (the ... pill"). The Obama Administration also announced that it ... held, for-profit corporations. The regulations issued ...
(Date:8/22/2014)... Aug. 22, 2014  Dr. Mark Rasak , ... Diamond Lifetime Achievement Award in the field of Medicine ... Cardiovascular Clinical Associates. Dr. Rasak has over ... major aspects of the business; overseeing the daily operations; ... coronary intervention. In addition, he is an honored Fellow ...
(Date:8/22/2014)... ., Aug. 22, 2014  Research presented at the 29 ... being developed by Hera Therapeutics Inc. combats three types of ... all cervical cancer. When tested in several cultured ... and HPV-11 cells, according to Louise T. Chow , ... findings at the Seattle conference. The ...
Breaking Medicine Technology:Liberty Institute: Government "Accommodation" Still Requires Employers To Facilitate Coverage Of Abortifacient Drugs 2Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2
Cached News: